International Biotechnology Trust plc - IBT
Investing in biotechnology for a healthier futureAccess the fast-growing biotechnology sector through an actively managed, diversified investment trust
Targeting high growth, International Biotechnology Trust plc (IBT) backs innovative companies addressing high unmet medical needs and offers investors the opportunity for financial returns.
Seeking the best in biotech
International Biotechnology Trust invests in around 100 of the most innovative, high quality quoted and unquoted companies across the entire spectrum of the biotech and other life sciences sectors.
A keen focus on risk management
An acute understanding of valuation and the biotechnology investment cycle informs the managers’ top down overlay and they take prudent steps to reduce individual company risk ahead of binary events. This has contributed to their outperformance against the index and their peers.
Income generating
A dividend of 4% of closing net asset value, paid biannually, offers investors a highly differentiated and reliable source of income.
IBT Manager Update
On Tuesday 28 January 2025, Portfolio Managers Ailsa Craig and Marek Poszepczynski gave insight on their 2025 market outlook
Download key material
Browse the latest factsheet, explore the latest Report and more for the International Biotechnology Trust plc
Portfolio & Performance Hub
Source: Morningstar, February 2025
Source: Association of Investment Companies, 2025
In the media
Documents
Invest in the International Biotechnology Trust plc (IBT)
It is easy to make regular, tax-efficient investments into investment trust shares with a UK online stockbroker. We recommend you seek financial advice from an independent adviser before making an investment decision.